These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8535955)

  • 1. Corneal vascularization and opacification during long-term use of dipivefrin.
    Salminen L; Krootila K; Helin H; Hakala T
    J Ocul Pharmacol Ther; 1995; 11(1):37-40. PubMed ID: 8535955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bulbar conjunctival follicles associated with dipivefrin therapy.
    Liesegang TJ
    Ophthalmology; 1985 Feb; 92(2):228-33. PubMed ID: 3982802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with the effectiveness and tolerance of guanethidine/dipivefrin-AT in the treatment of increased intraocular pressure].
    Ober M; Scharrer A
    Klin Monbl Augenheilkd; 1986 Jan; 188(1):64-6. PubMed ID: 3959479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic index of epinephrine and dipivefrin with nasolacrimal occlusion.
    Zimmerman TJ; Sharir M; Nardin GF; Fuqua M
    Am J Ophthalmol; 1992 Jul; 114(1):8-13. PubMed ID: 1621789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure].
    Ober M; Scharrer A; Dausch D
    Klin Monbl Augenheilkd; 1987 Feb; 190(2):103-4. PubMed ID: 3573660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution.
    Tsujinaka A; Takai Y; Inoue Y; Tanito M
    Acta Ophthalmol; 2019 Sep; 97(6):e948-e949. PubMed ID: 30609169
    [No Abstract]   [Full Text] [Related]  

  • 7. Dipivefrin and epinephrine treatment of elevated intraocular pressure: a comparative study.
    Kass MA; Mandell AI; Goldberg I; Paine JM; Becker B
    Arch Ophthalmol; 1979 Oct; 97(10):1865-6. PubMed ID: 39539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal sterile infiltration induced by topical use of ocular hypotensive agent.
    Manabe Y; Sawada A; Mochizuki K
    Eur J Ophthalmol; 2020 Sep; 30(5):NP23-NP25. PubMed ID: 31096781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A correlation between latanoprost-induced conjunctival hyperemia and intraocular pressure-lowering effect.
    Kobayashi H; Kobayashi K
    J Glaucoma; 2011 Jan; 20(1):3-6. PubMed ID: 20520573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adding betaxolol to dipivefrin therapy.
    Weinreb RN; Ritch R; Kushner FH
    Am J Ophthalmol; 1986 Feb; 101(2):196-8. PubMed ID: 3946535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An advance in ophthalmic pharmacology. The use of the epinephrine pro-drug dipivalyl epinephrine in the treatment of glaucoma.
    Garzia R
    J Am Optom Assoc; 1982 Sep; 53(9):727-30. PubMed ID: 7130613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular conjunctivitis on Dipivefrin therapy for glaucoma.
    Coleiro JA; Sigurdsson H; Lockyer JA
    Eye (Lond); 1988; 2 ( Pt 4)():440-2. PubMed ID: 3253137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring sensitivity to timolol after long-term drift in primary open-angle glaucoma.
    Gandolfi SA
    Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):354-8. PubMed ID: 2406218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The additive effect of dipivefrin in patients with wide angle glaucoma treated with long-term beta-blocker therapy in comparison with clonidine].
    Alimgil ML; Erda S; Benian O
    Klin Monbl Augenheilkd; 1994 Aug; 205(2):114-6. PubMed ID: 7967405
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of primary open-angle glaucoma by oftan-dipivefrin].
    Egorov EA; Alekseev VN; Erichev VP; Usachev VV; Simonova SV; Iakubova LV
    Vestn Oftalmol; 2000; 116(1):32-3. PubMed ID: 10741262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levobunolol compared to dipivefrin in African American patients with open angle glaucoma.
    Drake MV; Wilson MR; Harris D; Goodwin L
    J Ocul Pharmacol; 1993; 9(2):91-5. PubMed ID: 8123096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipivefrin: current concepts.
    Goldberg I; Kolker AE; Kass MA; Becker B
    Aust J Ophthalmol; 1980 May; 8(2):147-50. PubMed ID: 7004425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilocarpine and dipivefrin.
    Cantor LB
    CLAO J; 1991 Apr; 17(2):134. PubMed ID: 2049823
    [No Abstract]   [Full Text] [Related]  

  • 19. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
    Gandolfi SA; Vecchi M
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dipivefrin: its mechanism of action, clinical efficacy and good tolerance].
    Harper DG; Novack GD; Borrmann LR; Branin MJ
    Ophtalmologie; 1989; 3(4):306-7. PubMed ID: 2641142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.